4篇
您的检索式：作者名="Tang Chengwu"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Construction and expression of DNA vaccine pIRES-Sj97-Sj14-Sj26 and its immunogenicity in mice显示文摘 | Shuojie Liu Jizhong Cheng Chengwu Tang Yanbin Ma Shuyu Wang Ping Guo Qiuhong Duan Hong Gao Wuxing Dai | 2008 | Journal of Huazhong University of Science and Technology2008，，6： | 1 |
| 2 | Small-molecule diketopyrrolopyrrole-based therapeutic nanoparticles for photoacoustic imaging-guided photothermal therapy显示文摘治疗学的 nanoparticles (NP ) 基于 donor-acceptor-donor,结构化的小器官的分子 diketopyrrolopyrrole (SDPP ) 用一条简单降水途径被准备。这些在红外线附近的吸收放射的 NP 有高 photothermal 变换效率并且能有选择地通过提高的渗透和保留效果指向癌症纸巾。得益于这些优点, SDPP NP 能用作一个优秀治疗学的代理人为高度有效并且 noninvasive photoacoustic 指导成像的 photothermal 治疗。用老鼠肿瘤模型的实验证明 SDPP NP 在激光照耀下面展出了非凡的肿瘤脱离能力(660 nm, 1.0 W ? 敳獮瑩癩? 慮潮戭潩椠瑮牥慦散漠 ? 桴獩 ?? 楨牥牡档捩污祬猠牴 ' 壮肭?業牣景畬摩捩搠癥捩 ? 眠楨档猠潨敷 ? 楨桧攠晦捩敩据 ? 景 ?? 挠灡畴敲吗? | Yu Cai Weili Si Qianyun Tang Pingping Liang Chengwu Zhang Peng Chen QiZhang Wei Huang Xiaochen Dong | 2017 | Nano Research2017，10，3： | 1 |
| 3 | On the existence of cycle frames and almost resolvable cycle systems显示文摘 | Cao Haita Niu Meixin Tang Chengwu | 2011 | Discrete Math2011，311，： | 1 |
| 4 | Initial experience of laparoendoscopic single-site radical prostatectomy with a novel purpose-built robotic system显示文摘Objective This prospective single-arm clinical trial aimed to evaluated the feasibility and safety of the application of the SHURUI system(Beijing Surgerii Technology Co.,Ltd.,Beijing,China),a novel purpose-built robotic system,in single-port robotic radical prostatectomy.Methods Sixteen patients diagnosed with prostate cancer were prospectively enrolled in and underwent robotic radical prostatectomy from October 2021 to August 2022 by the SHURUI single-port robotic surgical system.The demographic and baseline data,surgical,oncological,and functional outcomes as well as follow-up data were recorded.Results The mean operative time was 226.3(standard deviation[SD]52.0)min,and the mean console time was 183.4(SD 48.3)min,with the mean estimated blood loss of 116.3(SD 90.0)mL.The mean length of postoperative hospital stay was 4.50(SD 0.97)days.Two patients had postoperative complications(Clavien-Dindo Grade II),and both patients improved after conservative treatment.All patients’postoperative prostate-specific antigen levels decreased to below 0.2 ng/mL 1 month after discharge.The mean prostate-specific antigen level further decreased to a mean of 0.0219(SD 0.0641)ng/mL 6 months after surgery.Thirty days postoperatively,12 out of 16 patients reported using no more than one urinary pad per day,and all patients reported satisfactory urinary control without the need for pads 6 months after surgery.Conclusion The SHURUI system is safe and feasible in performing radical prostatectomy via both transperitoneal and extraperitoneal approaches.Tumor control and urinary continence were satisfying for patients enrolled in.The next phase involves conducting a large-scale,multicenter randomized controlled trial to thoroughly assess the effectiveness and safety of the new technology in a broader population. | Zheng Wang Chao Zhang Chengwu Xiao Yang Wang Yu Fang Baohua Zhu Shouyan Tang Xiaofeng Wu Hong Xu Yi Zhou Lingfen Wu Zhenjie Wu Bo Yang Yi He Yi Liu Linhui Wang | 2023 | Asian Journal of Urology2023，10，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员